Autolus Therapeutics (AUTL) Other financing activities (2020 - 2024)

Autolus Therapeutics (AUTL) has 5 years of Other financing activities data on file, last reported at $7000.0 in Q4 2024.

• Quarterly Other financing activities fell 69.57% year-over-year to $7000.0 in Q4 2024, while the trailing twelve-month figure through Sep 2025 was $7000.0 (down 98.87% YoY) and the FY2024 annual result came in at $602000.0, up 2129.63% from the prior year.
• Other financing activities fell to $7000.0 in Q4 2024, from $185000.0 in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $391000.0 in Q4 2020 to a low of -$1000.0 in Q4 2021.
• A 5-year average of $126200.0 and a median of $121000.0 in 2022 frame the typical range for Other financing activities.
• Annual changes were most pronounced in 2021 — Other financing activities tumbled 100.26% — and 2024, when it surged 4525.0%.
• Tracing AUTL's Other financing activities over 5 years: stood at $391000.0 in 2020, then plunged by 100.26% to -$1000.0 in 2021, then soared by 11800.0% to $117000.0 in 2022, then sank by 80.34% to $23000.0 in 2023, then tumbled by 69.57% to $7000.0 in 2024.
• The last three Other financing activities figures came in at $7000.0 (Q4 2024), $185000.0 (Q3 2024), and $125000.0 (Q2 2024), per Business Quant data.